Skip to main content
. 2021 Dec 20;24(12):838–846. [Article in Chinese] doi: 10.3779/j.issn.1009-3419.2021.103.12

表 1.

倾向评分匹配法匹配前及匹配后患者临床病理信息

Clinicopathological characteristics between two period before and after propensity-score matching

Variables Before propensity-score matching After propensity-score matching
Early phase
(n=660)
Late phase
(n=2, 221)
P Early phase
(n=634)
Late phase
(n=634)
P
Values are mean±SD or median (IQR) or n (%) unless otherwise noted.
ASA: American Society of Anesthesiologists; BMI: body mass index; CCI: charlson comorbidity index; DLCO: diffusing capacity of the lungs for carbon monoxide; FEV1: forced expiratory volume in one second; IQR: interquartile range; SD: standard deviation.
Gender
  Male 346 (52.4) 1, 124 (50.6) 0.412 327 (51.6) 348 (54.9) 0.237
  Famale 314 (47.6) 1, 097 (49.4) 307 (48.4) 286 (45.1)
Age (yr) 62.3±10.6 60.6±9.9 < 0.001 62.0±10.6 60.8±10.3 0.043
Smoking history
  None 400 (60.6) 1, 435 (64.6) 0.060 394 (62.1) 362 (57.1) 0.067
  Yet 260 (39.4) 786 (35.4) 240 (37.9) 272 (42.9)
BMI (kg/m2) 24.0±3.2 24.5±12.8 0.292 24.0±3.2 24.0±3.3 0.976
CCI
  0 497 (75.3) 1, 718 (77.4) 0.237 478 (75.4) 507 (80.0) 0.281
  1 121 (18.3) 366 (16.5) 116 (18.3) 97 (15.3)
  2 29 (4.4) 114 (5.1) 28 (4.4) 22 (3.5)
  3 11 (1.7) 20 (0.9) 10 (1.6) 8 (1.3)
  4 1 (0.2) 2 (0.1) 1 (0.2) 0 (0.0)
  ≥5 0 (0.0) 1 (0.0) 1 (0.2) 0 (0.0)
Diameter of main lesion (cm) 2.6±1.4 2.4±1.5 0.016 2.6±1.4 2.5±1.6 0.441
FEV1 (L) 2.6±4.1 2.6±2.6 0.833 2.5±0.7 2.5±0.6 0.026
FEV1% 94.0±17.4 96.5±17.2 0.002 94.5±16.8 95.0±17.5 0.603
ASA
  Ⅰ 101 (15.3) 348 (15.7) 0.760 100 (15.8) 122 (19.2) 0.242
  Ⅱ 523 (79.2) 1, 766 (79.5) 499 (78.7) 485 (76.5)
  Ⅲ 35 (5.3) 106 (4.8) 34 (5.4) 27 (4.3)
  Ⅳ 1 (0.2) 1 (0.0) 1 (0.2) 0 (0.0)
Operation time (min) 189±55 160±49 < 0.001 186±53 185±55 0.86
Tumor location
  Right upper lobe 239 (36.2) 762 (34.3) 0.634 229 (36.1) 222 (35.0) 0.724
  Right lower lobe 124 (18.8) 447 (20.1) 60 (9.5) 55 (8.7)
  Right middle lobe 61 (9.2) 210 (9.5) 119 (18.8) 112 (17.7)
  Left upper lobe 144 (21.8) 453 (20.4) 139 (21.9) 141 (22.2)
  Left lower lobe 92 (13.9) 349 (15.7) 87 (13.7) 104 (16.4)
Procedure
  Lobectomy 635 (96.2) 2, 126 (95.7) 0.198 611 (96.4) 603 (95.1) 0.19
  Bilobectomy 18 (2.7) 46 (2.1) 16 (2.5) 15 (2.4)
  Pneumonectomy 4 (0.6) 22 (1.0) 4 (0.6) 5 (0.8)
  Sleeve lobectomy 3 (0.5) 27 (1.2) 3 (0.5) 11 (1.7)
Blood loss (mL) 100 (50-200) 30 (50-100) < 0.001 100 (50-200) 50 (30-100) < 0.001
Dissected nodal stations 6±2 6±1 0.016 6±2 7±2 < 0.001
Dissected lymph nodes 18±8 15±7 < 0.001 18±8 18±8 0.894
Histologic subtype
  Squamous cell 95 (14.4) 291 (13.1) 0.094 88 (13.9) 93 (14.7) 0.586
  Adenocarcinoma 511 (77.4) 1, 800 (81.0) 496 (78.2) 479 (75.6)
  Small cell 11 (1.7) 33 (1.5) 11 (1.7) 16 (2.5)
  Others 43 (6.5) 97 (4.4) 39 (6.2) 46 (7.3)
Pathological stage
  Ⅰ 445 (67.4) 1, 600 (72.0) 0.072 427 (67.4) 416 (65.6) 0.689
  Ⅱ 100 (15.2) 291 (13.1) 95 (15.0) 106 (16.7)
  Ⅲ 115 (17.4) 330 (14.9) 112 (17.7) 112 (17.7)